ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q4 2022 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2023-02-14

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $6.187M (100.0% shares, 0.0% debt)

Holdings (3)

— MEDAVAIL HOLDINGS INC 72.8%

Value $4.506M Shares 15,029,480 Est. Cost $5.03 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 19.0%

Value $1.173M Shares 1,038,296 Est. Cost $7.36 Unrealized -67.1%

LUNG PULMONX CORP 8.2%

Value $508K Shares 60,204 Est. Cost $48.97 Unrealized -80.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDAVAIL HOLDINGS INC	15,029,480	$4.506M	72.8%	$5.03	—	COM	58406B103
RPID	RAPID MICRO BIOSYSTEMS INC	1,038,296	$1.173M	19.0%	$7.36	-67.1%	CLASS A COM	75340L104
LUNG	PULMONX CORP	60,204	$508K	8.2%	$48.97	-80.6%	COM	745848101